Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9

Molecular Therapy : the Journal of the American Society of Gene Therapy
Hong-Xia ZhangHao Yin

Abstract

Genome-editing technologies based on programmable nucleases have significantly broadened our ability to make precise and direct changes in the genomic DNA of various species, including human cells. Delivery of programmable nucleases into the target tissue or cell is one of the pressing challenges in transforming the technology into medicine. In vitro-transcribed (IVT) mRNA-mediated delivery of nucleases has several advantages, such as transient expression with efficient in vivo and in vitro delivery, no genomic integration, a potentially low off-target rate, and high editing efficiency. This review focuses on key barriers related to IVT mRNA delivery, on developed modes of delivery, and on the application and future prospects of mRNA encoding nuclease-mediated genome editing in research and clinical trials.

Citations

Feb 26, 2020·Nanomaterials·Itziar Gómez-AguadoAna Del Pozo-Rodríguez
Apr 14, 2020·Expert Opinion on Drug Delivery·Shahin AghamiriHossein Ghanbarian
Aug 14, 2020·International Journal of Molecular Sciences·Sunny AhmarKi-Hong Jung
Sep 26, 2019·Frontiers in Genetics·Peter KaldsYulin Chen
Feb 12, 2020·Journal of Personalized Medicine·Chiara ArgentatiSabata Martino
Jan 16, 2020·Biomedicines·Andrei A DeviatkinAlexander N Lukashev
Sep 2, 2020·International Journal of Molecular Sciences·Andrés Felipe LealAngela Johana Espejo-Mojica
Apr 4, 2020·Molecular Biology Reports·Ibrahim Ilker Ozyigit
Nov 27, 2019·Cancers·Kenya KamimuraShuji Terai
Sep 24, 2020·Pharmaceutics·Yanfang Wang, Ernst Wagner
Nov 24, 2019·Advanced Drug Delivery Reviews·Cong-Fei XuJun Wang
Apr 5, 2020·Advanced Drug Delivery Reviews·Franziska Freitag, Ernst Wagner
Nov 23, 2020·Molecular Biology Reports·Ibrahim Ilker Ozyigit, Kuaybe Yucebilgili Kurtoglu
Jan 1, 2021·Frontiers in Oncology·Mariela Montaño-SamaniegoMiguel Ibáñez-Hernández
Dec 17, 2020·Neurological Research and Practice·David BrennerJochen H Weishaupt
Feb 23, 2021·The Journal of Biological Chemistry·Yoshiki NarimatsuHenrik Clausen
Mar 2, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Saed AbbasiKazunori Kataoka
Aug 30, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rui ZhangLi Yang
Aug 28, 2020·Molecular Pharmaceutics·Satoshi UchidaHoracio Cabral
Mar 30, 2021·Biologics : Targets & Therapy·Tafere Mulaw Belete
Jul 3, 2021·Journal of Personalized Medicine·Takashi MotomuraAlejandro Soto-Gutierrez
Aug 18, 2021·Advanced Drug Delivery Reviews·Maria L IbbaPaloma H Giangrande
Sep 13, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byung-Chul LeeCynthia E Dunbar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

© 2022 Meta ULC. All rights reserved